Russo Rene Insider Trades

Insider Trading History

Track insider trading activity for Russo Rene. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Xilio Therapeutics
Xilio Therapeutics XLO
PRESIDENT AND CEO
Holding Value $788k 88,500 shares
Last Trade
Jan 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$396k 44,250 shares
$8.96
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
PRESIDENT AND CEO
Holding Value $2.9M 325,422 shares
Last Trade
Jan 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$396k 44,250 shares
$8.96
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
PRESIDENT AND CEO
Holding Value $13.4M 1,500,258 shares
Last Trade
Dec 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.4M 1,500,258 shares
$8.96
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
PRESIDENT AND CEO
Holding Value $0 0 shares
Last Trade
Nov 21, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$23.2M 2,198,212 shares
$10.54
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
PRESIDENT AND CEO
Holding Value $18.5M 2,075,000 shares
Last Trade
Nov 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45M 4,273,212 shares
$10.54
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
PRESIDENT AND CEO
Holding Value $2.5M 281,172 shares
Last Trade
Jun 16, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$24.7k 36,289 shares
$0.68
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
PRESIDENT AND CEO
Holding Value $1.69M 190,000 shares
Last Trade
Apr 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$135k 190,000 shares
$0.71
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
PRESIDENT AND CEO
Holding Value $5.68M 638,000 shares
Last Trade
Jan 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$612k 638,000 shares
$0.96
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
PRESIDENT AND CEO
Holding Value $2.18M 244,883 shares
Last Trade
Jan 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$42.3k 44,250 shares
$0.96
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
PRESIDENT AND CEO
Holding Value $1.18M 132,750 shares
Last Trade
Jan 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$42.3k 44,250 shares
$0.96
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
PRESIDENT AND CEO
Holding Value $4.22M 474,000 shares
Last Trade
May 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$512k 474,000 shares
$1.08
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
PRESIDENT AND CEO
Holding Value $1.58M 177,000 shares
Last Trade
Jan 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$97.4k 177,000 shares
$0.55
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
CEO
Holding Value $6.23M 700,000 shares
Last Trade
Aug 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.95M 700,000 shares
$2.79
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
Director, CEO
Holding Value $3.12M 350,000 shares
Last Trade
Jan 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$942k 350,000 shares
$2.69
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
CEO AND PRESIDENT
Holding Value $1.34M 150,000 shares
Last Trade
Feb 22, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.9M 150,000 shares
$12.66
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
CEO AND PRESIDENT
Holding Value $890k 100,000 shares
Last Trade
Dec 22, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.38M 100,000 shares
$13.83
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
CEO AND PRESIDENT
Holding Value $890k 100,000 shares
Last Trade
Dec 22, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.38M 100,000 shares
$13.83
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
10% owner, CEO And President
Holding Value $1.79M 200,633 shares
Last Trade
Oct 21, 2021 Sale
No data
No data
$8.90
Xilio Therapeutics
Xilio Therapeutics XLO
10% owner, CEO And President
Holding Value $445k 50,041 shares
Last Trade
Oct 21, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$8.90
Adagio Therapeutics
Adagio Therapeutics ADGI
Director
Holding Value $165k 35,593 shares
Last Trade
Aug 05, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$4.64

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up